184 related articles for article (PubMed ID: 6202346)
1. In vitro activation of the contact (Hageman factor) system of plasma by heparin and chondroitin sulfate E.
Hojima Y; Cochrane CG; Wiggins RC; Austen KF; Stevens RL
Blood; 1984 Jun; 63(6):1453-9. PubMed ID: 6202346
[TBL] [Abstract][Full Text] [Related]
2. Mast cell derived heparin activates the contact system: a link to kinin generation in allergic reactions.
Brunnée T; Reddigari SR; Shibayama Y; Kaplan AP; Silverberg M
Clin Exp Allergy; 1997 Jun; 27(6):653-63. PubMed ID: 9208186
[TBL] [Abstract][Full Text] [Related]
3. A different cleavage site for high molecular weight kininogen in vivo following intravenous injection of dextran sulfate in the rabbit.
Wiggins RC
Circ Res; 1986 Apr; 58(4):595-604. PubMed ID: 2421941
[TBL] [Abstract][Full Text] [Related]
4. The binding and cleavage characteristics of human Hageman factor during contact activation. A comparison of normal plasma with plasmas deficient in factor XI, prekallikrein, or high molecular weight kininogen.
Revak SD; Cochrane CG; Griffin JH
J Clin Invest; 1977 Jun; 59(6):1167-75. PubMed ID: 864009
[TBL] [Abstract][Full Text] [Related]
5. The contact activation mechanism in human plasma: activation induced by dextran sulfate.
van der Graaf F; Keus FJ; Vlooswijk RA; Bouma BN
Blood; 1982 Jun; 59(6):1225-33. PubMed ID: 6177360
[TBL] [Abstract][Full Text] [Related]
6. Mechanisms for the involvement of high molecular weight kininogen in surface-dependent reactions of Hageman factor.
Griffin JH; Cochrane CG
Proc Natl Acad Sci U S A; 1976 Aug; 73(8):2554-8. PubMed ID: 1066663
[TBL] [Abstract][Full Text] [Related]
7. Interactions among Hageman factor, plasma prekallikrein, high molecular weight kininogen, and plasma thromboplastin antecedent.
Ratnoff OD; Saito H
Proc Natl Acad Sci U S A; 1979 Feb; 76(2):958-61. PubMed ID: 284420
[TBL] [Abstract][Full Text] [Related]
8. Initiation of plasma prorenin activation by Hageman factor-dependent conversion of plasma prekallikrein to kallikrein.
Sealey JE; Atlas SA; Laragh JH; Silverberg M; Kaplan AP
Proc Natl Acad Sci U S A; 1979 Nov; 76(11):5914-8. PubMed ID: 42905
[TBL] [Abstract][Full Text] [Related]
9. Studies on prekallikrein of bovine plasma. II. Activation of prekallikrein with proteinases and properties of kallikrein activated by bovine Hageman factor.
Takahashi H; Nagasawa S; Suzuki T
J Biochem; 1980 Jan; 87(1):23-34. PubMed ID: 6766924
[TBL] [Abstract][Full Text] [Related]
10. Inhibition of the function of activated properdin by squid chondroitin sulfate E glycosaminoglycan and murine bone marrow-derived mast cell chondroitin sulfate E proteoglycan.
Wilson JG; Fearon DT; Stevens RL; Seno N; Austen KF
J Immunol; 1984 Jun; 132(6):3058-63. PubMed ID: 6427331
[TBL] [Abstract][Full Text] [Related]
11. Identification of prekallikrein and high-molecular-weight kininogen as a complex in human plasma.
Mandle RJ; Colman RW; Kaplan AP
Proc Natl Acad Sci U S A; 1976 Nov; 73(11):4179-83. PubMed ID: 1069308
[TBL] [Abstract][Full Text] [Related]
12. Cleavage of human high molecular weight kininogen markedly enhances its coagulant activity. Evidence that this molecule exists as a procofactor.
Scott CF; Silver LD; Schapira M; Colman RW
J Clin Invest; 1984 Apr; 73(4):954-62. PubMed ID: 6561202
[TBL] [Abstract][Full Text] [Related]
13. Activation and function of human Hageman factor. The role of high molecular weight kininogen and prekallikrein.
Meier HL; Pierce JV; Colman RW; Kaplan AP
J Clin Invest; 1977 Jul; 60(1):18-31. PubMed ID: 874082
[TBL] [Abstract][Full Text] [Related]
14. Effect of heparin on the activation of factor XII and the contact system in plasma.
Pixley RA; Cassello A; De La Cadena RA; Kaufman N; Colman RW
Thromb Haemost; 1991 Nov; 66(5):540-7. PubMed ID: 1725067
[TBL] [Abstract][Full Text] [Related]
15. Heparin affects the interaction of kininogen on endothelial cells.
Gozzo AJ; Motta G; Cruz-Silva I; Nunes VA; Barros NM; Carmona AK; Sampaio MU; Michelacci YM; Shimamoto K; Nader HB; Araújo MS
Biochimie; 2011 Oct; 93(10):1839-45. PubMed ID: 21784122
[TBL] [Abstract][Full Text] [Related]
16. Role of high-molecular-weight kininogen in surface-binding and activation of coagulation Factor XI and prekallikrein.
Wiggins RC; Bouma BN; Cochrane CG; Griffin JH
Proc Natl Acad Sci U S A; 1977 Oct; 74(10):4636-40. PubMed ID: 270705
[TBL] [Abstract][Full Text] [Related]
17. The role of prekallikrein and high-molecular-weight kininogen in the contact activation of Hageman factor (factor XII) by sulfatides and other agents.
España F; Ratnoff OD
J Lab Clin Med; 1983 Oct; 102(4):487-99. PubMed ID: 6604770
[TBL] [Abstract][Full Text] [Related]
18. Activation of rabbit Hageman factor by homogenates of cultured rabbit endothelial cells.
Wiggins RC; Loskutoff DJ; Cochrane CG; Griffin JH; Edgington TS
J Clin Invest; 1980 Jan; 65(1):197-206. PubMed ID: 6444222
[TBL] [Abstract][Full Text] [Related]
19. Activation of factor XII and prekallikrein with polysaccharide sulfates and sulfatides: comparison with kaolin-mediated activation.
Shimada T; Sugo T; Kato H; Yoshida K; Iwanaga S
J Biochem; 1985 Feb; 97(2):429-39. PubMed ID: 2861197
[TBL] [Abstract][Full Text] [Related]
20. Induction of vascular permeability enhancement by human tryptase: dependence on activation of prekallikrein and direct release of bradykinin from kininogens.
Imamura T; Dubin A; Moore W; Tanaka R; Travis J
Lab Invest; 1996 May; 74(5):861-70. PubMed ID: 8642782
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
